Adaptive Biotechnologies JP Morgan Healthcare Conference, Day 1: Guardant Health, Exact Sciences, Bruker, 10x Genomics, More Highlights from the first day included Exact Sciences' profitability forecast, an update on QuidelOrtho's integration, and Guardant Health's "quantum leap forward" with its "smart" liquid biopsy platform. New Products Posted to GenomeWeb: Thermo Fisher, Adaptive Biotech, Qiagen, Dolomite Bio, More New products and services posted to GenomeWeb for the week of Nov. 28, 2022. Adaptive Bio Narrows 2022 Revenue Guidance, Outlines Financial Expectations Releasing Q3 results, the Seattle-based immune system biotechnologies firm set its new full-year revenue guidance to the range of $185 million to $190 million. Adaptive Biotechnologies Inks Partnership to Integrate MRD Assay With Epic's EMR System After the expected integration in 2023, providers can order Adaptive’s ClonoSeq assay and review the results using the Epic electronic medical record system. Adaptive Biotechnologies Inks Financing Deal Worth up to $250M The Seattle-based biotech company will receive the money in exchange for a percentage of its GAAP revenues. Aug 4, 2022 Adaptive Biotechnologies Halts T-Detect Commercialization, Reports 13 Percent Q2 Revenue Growth Premium Jul 28, 2022 Adaptive Biotech's ClonoSeq Gets Expanded Medicare Coverage For B-Cell Lymphoma Jun 21, 2022 Adaptive Biotechnologies Looks to Refocus T-Cell Profiling Tech in Wake of Restructuring Premium Jun 17, 2022 New Products Posted to GenomeWeb: Roche, Adaptive Biotech, GenTegra, More May 5, 2022 Adaptive Biotechnologies Making Inroads in MRD, Immune Medicine Businesses Premium May 4, 2022 Adaptive Biotechnologies Q1 Revenues Rise Slightly in Q1 Mar 11, 2022 People in the News: New Appointments at Adaptive Biotech, NeoGenomics, Biological Dynamics, More Mar 9, 2022 Adaptive Biotechnologies Cuts Workforce as Part of Restructuring, Appoints New CFO Mar 3, 2022 Adaptive Biotechnologies Makes Progress Toward T-Cell Assay for Inflammatory Bowel Disease Premium Mar 1, 2022 Stocks of Omics Tools, MDx Firms Find More Stable Footing in February After Tough Start to Year Feb 16, 2022 Adaptive Biotechnologies to Focus on Immune Medicine, Minimal Residual Disease Testing Businesses Premium Feb 15, 2022 Adaptive Biotechnologies Revenues Rise 26 Percent in Q4, 57 Percent in 2021 Jan 11, 2022 JPM Healthcare Conference Day 1: Seer, Twist, 10x, Guardant, Natera, Bruker, Adaptive, Qiagen, Sema4 Jan 10, 2022 Akoya, Olink, NanoString, Adaptive Bio, Sema4, Oxford Nanopore Report Preliminary Financial Results Jan 4, 2022 Fulgent Genetics, Bio-Techne Lead Winners as GenomeWeb Index Gains 12 Percent in 2021 Nov 5, 2021 Adaptive Biotechnologies' T-Cell Assay Plans Boosted by Medicare Nod for COVID Test Premium Nov 3, 2021 Adaptive Biotechnologies Q3 Revenues Rise 50 Percent Oct 1, 2021 New Products Posted to GenomeWeb: Adaptive Biotechnologies, Amazon, Thermo Fisher, More Aug 13, 2021 People in the News: New Appointments at BD, Adaptive Biotechnologies, ChromaCode, More Aug 4, 2021 Adaptive Biotechnologies Q2 Revenues Jump 83 Percent Load More Breaking News Cancer Prognoses Informed by Module-Based Approach, Study Finds People in the News at Illumina, Centogene, BioSkryb New Products Posted to GenomeWeb: Bio-Rad, BD, Analytik Jena, BioMérieux Genetic Technologies to Raise A$5M in Direct Stock Offering In Brief This Week: SD Biosensors, Meridian, Oncocyte, Opko Health, GeneDx, More The Scan Study Reveals New Details About Genetics of Major Cause of Female Infertility Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency. Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis. Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven. White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.